CNRS FRE 3011 VirPath, Virologie et Pathologie Humaine, Faculté de médecine RTH Laennec, Université Claude Bernard Lyon 1, Université de Lyon, F-69008, Lyon, France.
Virus Res. 2009 Dec;146(1-2):115-24. doi: 10.1016/j.virusres.2009.09.009. Epub 2009 Sep 19.
The entry of enveloped viruses into host cells is accomplished by fusion of the viral envelope with the target cell membrane. For the paramyxovirus parainfluenza virus type 5 (PIV-5), this fusion involves an attachment protein (HN) and a class I viral fusion protein (F). We investigated the effect of 20 different combinations of 12 amino-acid substitutions within functional domains of the PIV-5 F glycoprotein, by performing cell surface expression measurements, quantitative fusion and syncytia assays. We found that combinations of mutations conferring an autonomous phenotype with mutations leading to an increased fusion activity were compatible and generated functional PIV-5 F proteins. The addition of mutations in the heptad-repeat domains led to both autonomous and hyperfusogenic phenotypes, despite the low cell surface expression of the corresponding mutants. Such engineering approach may prove useful not only for deciphering the fundamental mechanism behind viral-mediated membrane fusion but also in the development of potential therapeutic applications.
包膜病毒进入宿主细胞是通过病毒包膜与靶细胞膜融合来实现的。对于副黏病毒副流感病毒 5 型(PIV-5),这种融合涉及附着蛋白(HN)和 I 类病毒融合蛋白(F)。我们通过进行细胞表面表达测量、定量融合和合胞体测定,研究了 PIV-5 F 糖蛋白功能域内 20 种不同的 12 个氨基酸取代组合的影响。我们发现,赋予自主表型的突变组合与导致融合活性增加的突变组合是相容的,并产生了功能性的 PIV-5 F 蛋白。在七肽重复结构域中添加突变导致了自主和超融合表型,尽管相应突变体的细胞表面表达水平较低。这种工程方法不仅可能有助于阐明病毒介导的膜融合背后的基本机制,而且可能有助于开发潜在的治疗应用。